Skip to main content
. 2021 Apr 1;12:628296. doi: 10.3389/fneur.2021.628296

Table 1.

Twenty-three adults in UK with pathologically-confirmed HIV-associated CD8 encephalitis (HIV-CD8E).

Case Age/sex Previous (months) Current ART CPE score Risk event category Clinical presentation Imaging CSF Cortico-steroids Outcome Diagnosis mode
CD4 c/μL pVL c/mL CD4 c/μL CD8 c/μL pVL c/mL Cells Protein g/L VL c/mL
1a 32/F 122 (3) 1,193 (3) 95 ND 291 Stopped Z, Em, s/L 3 m previously 8 4 17 d headache, confusion Typical 12 ly 0.4 ND No Died of HIV-CD8E Autopsy
2 40/M 547 (4) 19,126 543 NA 21,359 Nil 0 6 28 d headache, confusion, Typical 17 ly 1.35 ND Yes Died of HIV-CD8E Autopsy
3 28/F 847 (3) <50 (3) 876 2,001 <50 D, Z, r/L 9 1 7 d headache, confusion Typical 20 ly ND ND No Died of HIV-CD8E Autopsy
4 46/F 360 (4) 2,600 (4) 170 960 86,800 stopped A, T, r/S 4 m previously 5 3 Cardiac arrest ND ND ND ND No Died of HIV-CD8E Autopsy
5 40/M NA NA 315 306 <50 F, r/S 3 2 10 d confusion Typical ND ND ND No Died of HIV-CD8E Autopsy
6 36/M 847 (3) <50 (3) >400 NA 3,568 D, Z, r/L 9 3 7 d headache, confusion, fits Typical ND ND ND No Died of HIV-CD8E Autopsy
7 43/F 410 (4) <50 (4) 240 1,290 <50 T, D, r/A 5 1 21 d headache, TIA Typical 8 ly 0.68 ND No Died of HIV-CD8E Autopsy
8 47/F 1,030 (5) <50 (5) 824 1,755 238 r/A 2 3 7 d headache, confusion Typical NA >0.8 ND No Died of HIV-CD8E Autopsy
9b 49/F 521 (4) 28,808 (4) 374 970 12,062 T, A, r/A 6 4 28 d cognitive impairment Typical ND ND ND No Survived Brain biopsy
10 29/F 530 (3) NA 560 960 <50 L, A, r/L 7 1 5 d headache, obtunded Typical ND ND ND No Died of HIV-CD8E Autopsy
11 41/F NA 151,544 (3) 266 NA 439 A, M, R, r/L 12 3 4 d headache, cardiac arrest ND ND ND ND No Died of PE following recovery Autopsy
12 44/M 298 (3) <50 (3) 233 896 <50 E, r/D 5 1 28 d headache, 17 d confused Typical 80 ly 1.2 <50 Yes Died of HIV-CD8E Autopsy
13 37/F 1,032 (5) <50 (5) 353 880 8,759 stopped T, Em, r/S 1 m previously 5 2 + 3 28 d headache, 6 d vomiting Typical ND ND ND No Died of HIV-CD8E Autopsy
14 19/M 10 (4) NA 64 NA 600 T, Em, Ef 7 4 21 d limb paraesthesia 7 d seizures Typical ND ND ND Yes Survived Brain biopsy
15 33/F 370 (3) 340 (7) 200 1,340 8,300 Nil 0 6 Found dead (at home) ND ND ND ND No Died of HIV-CD8E and DILS Autopsy
16 51/F 1,024 (5) <50 (5) ND ND ND T, Em, r/D 7 2 4 d headache, vomiting Typical ND ND ND No Died of HIV-CD8E Autopsy
17cz 52/F 870 (3) <50 (3) 220 360 <50 T, Em, r/A 6 2 21 d headache, confusion, drowsy Typical ND ND 1,100 = VE Yes Survived Brain biopsy
18 33/F 450 (11) <50 (11) 348 741 3,300 M, r/D 9 3 28 d headache, cardiac arrest; second trimester pregnancy Typical NA NA 7,700 = VE No Died of HIV-CD8E Autopsy
19 35/F 594 (3) 91,201 (3) 487 703 125,893 stopped r/D 5 m previously 3 3 14 d headache, confusion Typical ND ND ND Yes Survived Brain biopsy
20 52/F 1,283 (8) 460 (2) ND ND ND T, Em, c/D 7 1 10 d headache, vomiting, ataxia, coned Typical ND ND ND No Died of HIV-CD8E Autopsy
21a 45/M 50 (2.5) 838,000 (2.5) 320 ND 4,000 E, L, Z 8 4V 7 d worsening of long-standing cognitive decline: 2 d generalized seizures Typical 23 ly 1.15 ND No Died of HIVE and HIV-CD8E Autopsy
22 45/M 520 (12) <50 (7) ND ND ND L, M, r/A 7 2 3 d worsening of long-standing cognitive decline ND ND ND ND No Died of HIV-CD8E Autopsy
23 69/M 400 (13) <50 (13) 460 NA <50 T, Em, N 8 1V 10 d headache, confusion 2 d seizures Typical 26 0.56 <50 Yes Died of HIV-CD8E Autopsy

Previously published references:

a

(1);

b

(13);

c

(11). Key: d, days; m, months; c/μL, cells/μL; pVL, plasma viral load (c/mL: copies/mL); VL, viral load (c/mL: copies/mL); ND, not done; NA, not available; ART, antiretroviral therapy; A, abacavir; c/D, cobicistat-boosted darunavir; D, didanosine; E, etravirine; Ef, efavirenz; Em, emtricitabine; F, fosamprenavir; L, lamivudine; M, maraviroc; N, nevirapine; r/A, ritonavir-boosted atazanavir; r/D, ritonavir-boosted darunavir; r/L, ritonavir-boosted lopinavir; r/S, ritonavir-boosted saquinavir; R, raltegravir; T, tenofovir; Z, zidovudine; PE, pulmonary thromboembolism; TIA, transient ischaemic attack; HIV-CD8E, HIV-CD8 encephalitis; VE, CSF viral escape; ly, lymphocytes; HIVE, HIV encephalitis; DILS, diffuse infiltrative lymphocytosis syndrome. Risk event: 1, well-controlled HIV infection, occurring without identified risk event; 2, intercurrent infection or malignancy; 3, ART treatment interruption/poor adherence; 4, IRIS after commencing ART; 5, ART drug resistance; 6, not in receipt of ART; V, variant.